Standard qualification criteria include: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related health condition (high blood pressure, type 2 diabetes, high cholesterol) No history of certain medical conditions (medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2) Not pregnant or breastfeeding Top 8 GLP-1 Telehealth Providers Compared 1
Consider Retatrutide If: You have significant weight to lose (BMI 30+) and want maximum pharmaceutical efficacy
Clinical trials ran 48 to 72 weeks, showing continued benefit throughout treatment
In Eli Lilly's Phase 2 clinical trial (published in the New England Journal of Medicine, 2023), 338 adults with obesity or overweight (without diabetes) were treated with retatrutide for 48 weeks
"After three months, reevaluating progress with a medical provider can help determine appropriate next steps, including whether adding a GLP-1 medication is warranted."
Therefore, MOTS-c plays an important role in the regulation of cardiovascular, diabetes, exercise and longevity
